可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Rizza S,Copetti M,Rossi C,et al.Metabolomics signature improves the prediction of cardiovascular events in elderly subjects[J].Atherosclerosis,2014,232(2):260-264.
[2]Shih H,Lee B,Lee RJ,et al.The aging heart and post-infarction left ventricular remodeling[J].J Am Coll Cardiol,2011,57(1):9-17.
[3]French JK,Hellkamp AS,Armstrong PW,et al.Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction(from APEX-AMI)[J].Am J Cardiol,2010,105(1):59-63.
[4]Solhpour A,Chang KW,Balan P,et al.Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction[J].Am J Cardiol,2014,113(1):60-63.
[5]Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials[J].Lancet,2003,361(9351):13-20.
[6]Alexander KP,Newby LK,Armstrong PW,et al.Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric[J].Circulation,2007,115(19):2570-2589.
[7]De BE,Ottervanger MJ,Hof JV,et al.Reperfusion therapy in elderly patients with acute myocardial infarction:a randomized comparison of primary angioplasty and thrombolytic therapy[J].J Am Coll Cardiol,2002,39(12):1723-1728.
[8]Dzavik V,Sleeper LA,Cocke TP,et al.Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry[J].Eur Heart J,2003,24(9):828-837.
[9]WRITING GROUP MEMBERS,Lloyd-Jones D,Adams RJ,et al.Heart disease and stroke statistics--2010 update: a report from the American Heart Association[J].Circulation,2010,121(7):e46-e215.
[10]Gould KE,Taffet GE,Michael LH,et al.Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure[J].Am J Physiol Heart Circ Physiol,2002,282(2):H615-H621.
[11]Olivetti G,Abbi R,Quaini F,et al.Apoptosis in the failing human heart[J].N Engl J Med,1997,336(16):1131-1141.
[12]Hayakawa K,Takemura G,Koda M,et al.Sensitivity to apoptosis signal, clearance rate, and ultrastructure of fas ligand-induced apoptosis in in vivo adult cardiac cells[J].Circulation,2002,105(25):3039-3045.
[13]Kajstura J,Rota M,Cappetta D,et al.Cardiomyogenesis in the aging and failing human heart[J]. Circulation,2012,126(15):1869-1881.
[14]Nakai A,Yamaguchi O,Takeda T,et al.The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress[J].Nat Med,2007,13(5):619-624.
[15]Matsui Y,Takagi H,Qu X,et al.Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy[J].Circ Res,2007,100(6):914-922.
[16]Rajawat YS,Hilioti Z,Bossis I.Aging:central role for autophagy and the lysosomal degradative system[J]. Ageing Res Rev,2009,8(3):199-213.
[17]Ellison GM,Waring CD,Vicinanza C,et al.Physiological cardiac remodelling in response to endurance exercise training:cellular and molecular mechanisms[J].Heart,2012,98(1):5-10.
[18]Chimenti C,Kajstura J,Torella D,et al.Senescence and death of primitive cells and myocytes Lead to premature cardiac aging and heart failure[J].Circ Res,2003,93(7):604-613.
[19]Bergmann O,Bhardwaj RD,Bernard S,et al.Evidence for cardiomyocyte renewal in humans[J].Science,2009,324(5923):98-102.
[20]Thomas DP,Cotter TA, Li X,et al.Exercise training attenuates aging-associated increases in collagen and collagen crosslinking of the left but not the right ventricle in the rat[J].Eur J Appl Physiol,2001,85(1-2):164-169.